Changing the paradigm: lobectomy for sporadic medullary thyroid cancer
European Thyroid Journal · 01.04.2025 · 14 (2)
DOI: 10.1530/etj-25-0040 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Thyroid Journal, online erschienen am 31.03.2025. Verfasst von Marina Lugaresi und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroidectomy, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objectives
Total thyroidectomy is the treatment of choice for medullary thyroid cancer (MTC), although the sporadic forms are usually monocentric. Aim of the present study was to evaluate i) the performance of calcitonin (Ct) levels, ultrasound scans (US) and cytology in the preoperative identification of MTC and ii) the number of total thyroidectomies that could have been avoided being the location of the MTC diagnosed preoperatively. Materials and methods We retrospectively analyzed 89 RET germline negative patients diagnosed with MTC in the past 30 years, treated with total thyroidectomy ± lymphadenectomy, and followed in our Tertiary Care Center. In a subgroup of 55 patients, divided in those with a mono- or bi-lateral goiter, we applied ex-post criteria for the presurgical identification of the lobe holding the MTC nodule.
Results
Only 2/89 patients (2.2%) had a bilateral MTC at histology. A strongly significant correlation was found between preoperative basal Ct levels and MTC size. According to the ex-post identification criteria, the 84.4 and 56.5% of the nodules would have been identified preoperatively as MTC in monolateral and bilateral goiters, respectively.
Conclusions
This is the first European study that aims to evaluate the feasibility of lobectomy as first-line therapy for MTC based on the evaluation of thyroid US and serum Ct levels. These tools have been shown to have a good accuracy in detecting the affected lobe and strongly support the possibility to perform a more conservative surgery to treat RET-negative patients with suspicious MTC and nodular goiter.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
ORCID-Profile: Laura Fugazzola
Zitieren
APA
Lugaresi, M., Moneta, C., Saruggia, G., Dionigi, G., Gazzano, G., & Fugazzola, L. (2025). Changing the paradigm: lobectomy for sporadic medullary thyroid cancer. European Thyroid Journal, 14(2). https://doi.org/10.1530/etj-25-0040
Vancouver
Lugaresi M, Moneta C, Saruggia G, Dionigi G, Gazzano G, Fugazzola L. Changing the paradigm: lobectomy for sporadic medullary thyroid cancer. European Thyroid Journal. 2025;14(2). doi:10.1530/etj-25-0040
BibTeX
@article{Lugaresi2025,
author = {Lugaresi, Marina and Moneta, Claudia and Saruggia, Giulia and Dionigi, Gianlorenzo and Gazzano, Giacomo and Fugazzola, Laura},
title = {Changing the paradigm: lobectomy for sporadic medullary thyroid cancer},
journal = {European Thyroid Journal},
year = {2025},
volume = {14},
number = {2},
doi = {10.1530/etj-25-0040}
}
EUVIMED